Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy. (Q51604880)
Jump to navigation
Jump to search
scientific article published in March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy. |
scientific article published in March 2011 |
Statements
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy. (English)
1 reference
Stefan Bierer
1 reference
Ina Hoffmeister
1 reference
Joachim Gerss
1 reference
Edwin Herrmann
1 reference
Christian Wülfing
1 reference
Walter Sibrowski
1 reference
Lothar Hertle
1 reference
Reinhard Kelsch
1 reference
1 March 2011
1 reference
34
1 reference
2
1 reference
196-201
1 reference